The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ioversol-Global Market Insights and Sales Trends 2025
Synopsis
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
The global Ioversol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ioversol in various end use industries. The expanding demands from the X-ray, CT Scan, Brain Disorders and Blood Vessel Disorders, are propelling Ioversol market. Ioversol 34% Injectable Solution (Optiray 160), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ioversol 51% Injectable Solution (Optiray 240) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ioversol market, driven by demand from China, the second largest economy with some signs of stabilising, the Ioversol market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ioversol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ioversol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ioversol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ioversol sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ioversol covered in this report include Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject, China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd and Stellence Pharmscience Pvt. Ltd, etc.
The global Ioversol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Global Ioversol market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ioversol market, Segment by Type:
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Global Ioversol market, by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ioversol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ioversol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
The global Ioversol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ioversol in various end use industries. The expanding demands from the X-ray, CT Scan, Brain Disorders and Blood Vessel Disorders, are propelling Ioversol market. Ioversol 34% Injectable Solution (Optiray 160), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ioversol 51% Injectable Solution (Optiray 240) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ioversol market, driven by demand from China, the second largest economy with some signs of stabilising, the Ioversol market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ioversol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ioversol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ioversol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ioversol sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ioversol covered in this report include Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject, China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd and Stellence Pharmscience Pvt. Ltd, etc.
The global Ioversol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Global Ioversol market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ioversol market, Segment by Type:
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Global Ioversol market, by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ioversol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ioversol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ioversol Market Overview
1.1 Ioversol Product Overview
1.2 Ioversol Market Segment by Type
1.2.1 Ioversol 34% Injectable Solution (Optiray 160)
1.2.2 Ioversol 51% Injectable Solution (Optiray 240)
1.2.3 Ioversol 64% Injectable Solution (Optiray 300)
1.2.4 Ioversol 68% Injectable Solution (Optiray 320)
1.2.5 Ioversol 74% Injectable Solution (Optiray 350)
1.3 Global Ioversol Market Size by Type
1.3.1 Global Ioversol Market Size Overview by Type (2018-2029)
1.3.2 Global Ioversol Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ioversol Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ioversol Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ioversol Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ioversol Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ioversol Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ioversol Sales Breakdown by Type (2018-2023)
2 Global Ioversol Market Competition by Company
2.1 Global Top Players by Ioversol Sales (2018-2023)
2.2 Global Top Players by Ioversol Revenue (2018-2023)
2.3 Global Top Players by Ioversol Price (2018-2023)
2.4 Global Top Manufacturers Ioversol Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ioversol Market Competitive Situation and Trends
2.5.1 Ioversol Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ioversol Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ioversol as of 2022)
2.7 Date of Key Manufacturers Enter into Ioversol Market
2.8 Key Manufacturers Ioversol Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ioversol Status and Outlook by Region
3.1 Global Ioversol Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ioversol Historic Market Size by Region
3.2.1 Global Ioversol Sales in Volume by Region (2018-2023)
3.2.2 Global Ioversol Sales in Value by Region (2018-2023)
3.2.3 Global Ioversol Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ioversol Forecasted Market Size by Region
3.3.1 Global Ioversol Sales in Volume by Region (2024-2029)
3.3.2 Global Ioversol Sales in Value by Region (2024-2029)
3.3.3 Global Ioversol Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ioversol by Application
4.1 Ioversol Market Segment by Application
4.1.1 X-ray
4.1.2 CT Scan
4.1.3 Brain Disorders
4.1.4 Blood Vessel Disorders
4.1.5 Heart Disorders
4.1.6 Others
4.2 Global Ioversol Market Size by Application
4.2.1 Global Ioversol Market Size Overview by Application (2018-2029)
4.2.2 Global Ioversol Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ioversol Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ioversol Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ioversol Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ioversol Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ioversol Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ioversol Sales Breakdown by Application (2018-2023)
5 North America Ioversol by Country
5.1 North America Ioversol Historic Market Size by Country
5.1.1 North America Ioversol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ioversol Sales in Volume by Country (2018-2023)
5.1.3 North America Ioversol Sales in Value by Country (2018-2023)
5.2 North America Ioversol Forecasted Market Size by Country
5.2.1 North America Ioversol Sales in Volume by Country (2024-2029)
5.2.2 North America Ioversol Sales in Value by Country (2024-2029)
6 Europe Ioversol by Country
6.1 Europe Ioversol Historic Market Size by Country
6.1.1 Europe Ioversol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ioversol Sales in Volume by Country (2018-2023)
6.1.3 Europe Ioversol Sales in Value by Country (2018-2023)
6.2 Europe Ioversol Forecasted Market Size by Country
6.2.1 Europe Ioversol Sales in Volume by Country (2024-2029)
6.2.2 Europe Ioversol Sales in Value by Country (2024-2029)
7 Asia-Pacific Ioversol by Region
7.1 Asia-Pacific Ioversol Historic Market Size by Region
7.1.1 Asia-Pacific Ioversol Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ioversol Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ioversol Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ioversol Forecasted Market Size by Region
7.2.1 Asia-Pacific Ioversol Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ioversol Sales in Value by Region (2024-2029)
8 Latin America Ioversol by Country
8.1 Latin America Ioversol Historic Market Size by Country
8.1.1 Latin America Ioversol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ioversol Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ioversol Sales in Value by Country (2018-2023)
8.2 Latin America Ioversol Forecasted Market Size by Country
8.2.1 Latin America Ioversol Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ioversol Sales in Value by Country (2024-2029)
9 Middle East and Africa Ioversol by Country
9.1 Middle East and Africa Ioversol Historic Market Size by Country
9.1.1 Middle East and Africa Ioversol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ioversol Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ioversol Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ioversol Forecasted Market Size by Country
9.2.1 Middle East and Africa Ioversol Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ioversol Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Liebel-Flarsheim Company LLC
10.1.1 Liebel-Flarsheim Company LLC Company Information
10.1.2 Liebel-Flarsheim Company LLC Introduction and Business Overview
10.1.3 Liebel-Flarsheim Company LLC Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Liebel-Flarsheim Company LLC Ioversol Products Offered
10.1.5 Liebel-Flarsheim Company LLC Recent Development
10.2 Guerbet
10.2.1 Guerbet Company Information
10.2.2 Guerbet Introduction and Business Overview
10.2.3 Guerbet Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Guerbet Ioversol Products Offered
10.2.5 Guerbet Recent Development
10.3 Jiangsu Hengrui Medicine Co
10.3.1 Jiangsu Hengrui Medicine Co Company Information
10.3.2 Jiangsu Hengrui Medicine Co Introduction and Business Overview
10.3.3 Jiangsu Hengrui Medicine Co Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jiangsu Hengrui Medicine Co Ioversol Products Offered
10.3.5 Jiangsu Hengrui Medicine Co Recent Development
10.4 Mallinckrodt Pharmaceuticals
10.4.1 Mallinckrodt Pharmaceuticals Company Information
10.4.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
10.4.3 Mallinckrodt Pharmaceuticals Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mallinckrodt Pharmaceuticals Ioversol Products Offered
10.4.5 Mallinckrodt Pharmaceuticals Recent Development
10.5 Ultraject
10.5.1 Ultraject Company Information
10.5.2 Ultraject Introduction and Business Overview
10.5.3 Ultraject Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ultraject Ioversol Products Offered
10.5.5 Ultraject Recent Development
10.6 China Resources Pharmaceutical (Shanghai) Co
10.6.1 China Resources Pharmaceutical (Shanghai) Co Company Information
10.6.2 China Resources Pharmaceutical (Shanghai) Co Introduction and Business Overview
10.6.3 China Resources Pharmaceutical (Shanghai) Co Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.6.4 China Resources Pharmaceutical (Shanghai) Co Ioversol Products Offered
10.6.5 China Resources Pharmaceutical (Shanghai) Co Recent Development
10.7 HB Ocean
10.7.1 HB Ocean Company Information
10.7.2 HB Ocean Introduction and Business Overview
10.7.3 HB Ocean Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.7.4 HB Ocean Ioversol Products Offered
10.7.5 HB Ocean Recent Development
10.8 Novalek Pharmaceuticals Pvt. Ltd
10.8.1 Novalek Pharmaceuticals Pvt. Ltd Company Information
10.8.2 Novalek Pharmaceuticals Pvt. Ltd Introduction and Business Overview
10.8.3 Novalek Pharmaceuticals Pvt. Ltd Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novalek Pharmaceuticals Pvt. Ltd Ioversol Products Offered
10.8.5 Novalek Pharmaceuticals Pvt. Ltd Recent Development
10.9 Stellence Pharmscience Pvt. Ltd
10.9.1 Stellence Pharmscience Pvt. Ltd Company Information
10.9.2 Stellence Pharmscience Pvt. Ltd Introduction and Business Overview
10.9.3 Stellence Pharmscience Pvt. Ltd Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Stellence Pharmscience Pvt. Ltd Ioversol Products Offered
10.9.5 Stellence Pharmscience Pvt. Ltd Recent Development
10.10 A.S. Joshi & Company
10.10.1 A.S. Joshi & Company Company Information
10.10.2 A.S. Joshi & Company Introduction and Business Overview
10.10.3 A.S. Joshi & Company Ioversol Sales, Revenue and Gross Margin (2018-2023)
10.10.4 A.S. Joshi & Company Ioversol Products Offered
10.10.5 A.S. Joshi & Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ioversol Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ioversol Industrial Chain Analysis
11.4 Ioversol Market Dynamics
11.4.1 Ioversol Industry Trends
11.4.2 Ioversol Market Drivers
11.4.3 Ioversol Market Challenges
11.4.4 Ioversol Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ioversol Distributors
12.3 Ioversol Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
